Corbus CMO Barbara White resigns to accept another position, effective Sep 17

Corbus Pharmaceuticals Holdings, Inc.

Dr. Barbara White, Chief Medical Officer and Head of Research, resigns to join another company.
Her last day with Corbus will be September 17, 2021.
No replacement has been announced; separation agreement terms to be disclosed later.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Barbara White

Chief Medical Officer and Head of Research

CRBP · Corbus Pharmaceuticals Holdings, Inc.

Effective: 2021-09-17
Filed: August 18, 2021, 7:59 PM ET

On August 16, 2021, Barbara White, M.D., Chief Medical Officer and Head of Research of Corbus Pharmaceuticals Holdings, Inc. (the “Company”), submitted a notice of resignation to the Company to accept a position with another company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Barbara White resigned as Chief Medical Officer and Head of Research at Corbus Pharmaceuticals Holdings, Inc..

Action: resigned
Role: Chief Medical Officer and Head of Research

Exact text from the filing

On August 16, 2021, Barbara White, M.D., Chief Medical Officer and Head of Research of Corbus Pharmaceuticals Holdings, Inc. (the “Company”), submitted a notice of resignation to the Company to accept a position with another company.

View on SEC.gov

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-020508

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.